SEMAGLUTIDE - ORAL (SEM-a-GLOO-tide) COMMON BRAND NAME(S): Rybelsus WARNING: This medication can cause a certain type of thyroid tumor (thyroid C-cell tumors) in rats
PMID: 27 ShenYFanNMaS-XChengXYangXWangG
Other Alternatives in the GLP-1 Family Beyond Ozempic and Rybelsus, other GLP-1 medications are available
[DOI] [PubMed] [Google Scholar] 285.Verovski VN, Van den Berge DL, Soete GA, Bols BL, Storme GA
The brand's own footer disclosures note that "user results reflect recent internal statistics from paid orders" and that "rates may vary based on pharmacy capacity, state regulations, and individual order details." That means the 100,000+ figure reflects paid orders placed, not clinical outcomes
This, however, does not apply to other GLP-1RAs approved for the treatment of T2DM, including the same liraglutide (Victoza) and semaglutide (Ozempic or Rybelsus) at lower dosages, prompting several stakeholders to request an updated guidance 232 and more caution in media enthusiasm 233